These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8866652)

  • 1. Polyethylene glycol modification: relevance of improved methodology to tumour targeting.
    Francis GE; Delgado C; Fisher D; Malik F; Agrawal AK
    J Drug Target; 1996; 3(5):321-40. PubMed ID: 8866652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity.
    Malik F; Delgado C; Knüsli C; Irvine AE; Fisher D; Francis GE
    Exp Hematol; 1992 Sep; 20(8):1028-35. PubMed ID: 1505637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake.
    Moghimi M; Moghimi SM
    J Drug Target; 2008 Aug; 16(7):586-90. PubMed ID: 18686128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
    Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
    Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
    Hong M; Zhu S; Jiang Y; Tang G; Pei Y
    J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines.
    Gabizon A; Chemla M; Tzemach D; Horowitz AT; Goren D
    J Drug Target; 1996; 3(5):391-8. PubMed ID: 8866658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
    Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.
    Judge A; McClintock K; Phelps JR; Maclachlan I
    Mol Ther; 2006 Feb; 13(2):328-37. PubMed ID: 16275098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan.
    Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y
    J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation, successful approach to drug delivery.
    Veronese FM; Pasut G
    Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.
    Awasthi VD; Garcia D; Klipper R; Goins BA; Phillips WT
    J Pharmacol Exp Ther; 2004 Apr; 309(1):241-8. PubMed ID: 14718581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
    Maeda N; Takeuchi Y; Takada M; Sadzuka Y; Namba Y; Oku N
    J Control Release; 2004 Nov; 100(1):41-52. PubMed ID: 15491809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic method for peptide-PEG-lipid conjugates: application of octreotide-PEG-DSPE synthesis.
    Su JC; Tseng CL; Chang TG; Yu WJ; Wu SK
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4593-6. PubMed ID: 18656351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
    Lopez-Barcons LA; Polo D; Reig F; Fabra A
    J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.